Form 4: MiNK Therapeutics Director Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Director John Bradley Holcomb was granted 4,174 stock options in MiNK Therapeutics, Inc. as part of the company's equity incentive plan.
Summary
- Director John Bradley Holcomb received a grant of 4,174 stock options on September 23, 2025.
- The options have an exercise price of $14.92 per share.
- The options vest in three equal annual installments starting September 23, 2026, through September 23, 2028.
- The grant was issued under the MiNK Therapeutics, Inc. 2021 Amended and Restated Equity Incentive Plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Vesting is contingent upon the director maintaining a service relationship with the company.
Future Outlook
The options are set to vest over a three-year period, incentivizing the director's continued service through September 2028.
Management Comments
- The grant was made in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan.
Industry Context
StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practice in the biotechnology sector to ensure board alignment with long-term strategic goals.
Comparison to Industry Standards
- The use of a three-year vesting schedule is consistent with standard equity compensation practices for board members in small-cap biotech firms.
Stakeholder Impact
- Minor dilution impact on existing shareholders upon potential future exercise of options.
Next Steps
- Vesting of the first tranche of options on September 23, 2026.
Key Dates
| Date | Description |
|---|---|
| 09/23/2025 | Date of stock option grant and earliest transaction. |
| 09/23/2026 | First vesting date. |
| 09/23/2027 | Second vesting date. |
| 09/23/2028 | Third and final vesting date. |
| 09/23/2035 | Expiration date of the stock options. |
Keywords
MiNK Therapeutics, INKT, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.